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ABSTRACT The combined effects of cholesterol, a major cell membrane component, and the lipid second messenger
diacylglycerol on the activity of protein kinase C (PK-C) and the structure of phosphatidylcholine/phosphatidylserine bilayers
were investigated using speciﬁc PK-C assays and 2HNMR.Whereas the classical activation of PK-Cwas observed as an effect of
diacylglycerol, in the absence of this second messenger, cholesterol did not affect PK-C activity. A novel effect of ampliﬁed PK-C
activation was observed in the presence of both cholesterol and diacylglycerol concentrations within the physiological range of
each of these components. 2H NMR results suggest that this phenomenon is due to cholesterol- and diacylglycerol-induced
increased propensity of the lipids to adopt nonbilayer phases, effectively destabilizing the bilayer structure. The magnitude of the
effect wasa function of cholesterol concentration, implying that laterally separated cell membranedomainswith distinct cholesterol
concentrations have the capacity to differ in their sensitivity to extracellular stimuli.
INTRODUCTION
It has become generally accepted that plasma cell membranes
are not homogeneous structures, but contain laterally sepa-
rated regions with distinct lipid and protein compositions
(1–7). Although the precise nature of such regions is hotly
debated (see reviews (2,8,9)), the signature characteristics of
a subset of such regions (‘‘rafts’’) are increased cholesterol
and sphingomyelin content with corresponding changes in
physical properties, such as lipid chain order, membrane
thickness, and diffusion coefficients of lipid and protein
molecules contained in the rafts (1,2,9). Go´mez-Mouto´n et al.
(10) further demonstrated that there are multiple types of rafts
in cells, each with a specific complement of proteins, and that
the rafts played an important role in the migration of T
lymphocytes. Membrane rafts have additionally been impli-
cated in a diverse set of cellular processes, including signal
transduction (1), protein sequestration (11), heat shock re-
sponse (12), and intracellular trafficking (13).
A number of membrane-associated proteins are known to
be affected by the physical state and associated physico-
chemical parameters of the membrane, including protein
kinase C (PK-C) (14–17), phospholipase-A2 (18), G proteins
(19), colipase (20), and phospholipase C (PL-C) (21). The
ubiquitous membrane-associated signal transduction en-
zyme, PK-C, is a relatively well-studied example. PK-C is
involved in many cellular processes, including differentia-
tion, apoptosis, migration, adhesion, angiogenesis (22), and
tumorigenesis (23). Conventional isoforms of PK-C require
diacylglycerol, phosphatidylserine (PS), and Ca21 for their
activation. Furthermore, a number of studies from ours and
others’ laboratories have demonstrated that the activity of
PK-C is also modulated by the physicochemical parameters
of lipid bilayers and perturbations of these parameters in-
duced by diacylglycerols and other second messengers, such
as ceramides and unesterified fatty acids, thereby providing
an additional signal-integrating mechanism (14,15,24–27).
Diacylglycerols are produced primarily by the hydrolysis
of phosphatidylinositol 4,5-bisphosphate by PL-C to produce
diacylglycerol and inositol 1,4,5-trisphosphate (28,29). Ad-
ditional means of producing diacylglycerols are the degra-
dation of phosphatidylcholine by the phospholipase D/PAP
pathway (30) or the PL-C pathway (28). Beyond their role as
a second messenger in activating PK-C, diacylglycerols also
activate other proteins which contain a C1 domain, including
RasGRP, Chimaerin, and Munc family members (31). There
are at least 50 distinct molecular species of diacylglycerol in
mammalian cells (32,33), from polyunsaturated to saturated
variants, the polyunsaturated and mono-unsaturated variants
being the most biologically relevant. In this study, we used
diolein, a mono-unsaturated variant.
Cholesterol is an important constituent of cell membranes,
and has wide-ranging effects on the physico-chemical prop-
erties of membranes, including the average acyl chain order
(34), gel-to-liquid crystalline transition temperatures (35),
lateral diffusion rates (36), permeability of membranes to
ions, and the average area of lipid molecules (37). The mod-
ulation of membrane properties by cholesterol is also related
to the diverse biological effects of cholesterol, some of which
have been observed upon the removal of cholesterol by Mb-
cyclodextrin or other means, including the function of G
protein-coupled receptors (38), cytotoxicity of AbP in Alz-
heimer’s disease (39), and many others (40).
Here we extend our previous studies of the modulation by
membrane structure of membrane-associated signal trans-
duction proteins by examining the effects of cholesterol, di-
olein (a diacylglycerol), and sphingomyelin on PK-C activity
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and structure of phosphatidylcholine (PC)/PS bilayers using
PK-C assays and 2H NMR. The results show that cholesterol
is capable of modulating the activity of membrane-associated
signal transduction proteins, in addition to its previously
known membrane-ordering effects.
MATERIALS AND METHODS
Materials
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-palmitoyl-2-
oleoyl-sn-glycero-3-[phospho-L-serine] (POPS), 1-perdeuteriopalmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (d31-POPC), 1-perdeuteriopalmitoyl-
2-oleoyl-sn-glycero-3-[Phospho-L-Serine] (d31-POPS), bovine brain sphingo-
myelin, cholesterol, and diolein were purchased from Avanti Polar Lipids
(Alabaster, AL). Human recombinant PK-C-a was purchased from In-
vitrogen (Carlsbad, CA), Whatman P81 filter paper from Whatman (Kent,
UK), adenine triphosphate (ATP), Histone III-S, and morpholinopropane-
sulfonic acid (MOPS) from Sigma (St. Louis, MO). The g-32P ATP was
obtained from PerkinElmer (Boston, MA).
Methods
PK-C assays
A quantity of 300 nmol of POPC/POPS (4:1 mol/mol) in chloroform were
aliquoted into test tubes in triplicate along with diolein, cholesterol, and
sphingomyelin as the sample required. The chloroform was then evaporated
under dry N2 and then completely evaporated in a ,1 mTorr vacuum
overnight. The lipids were then hydrated with 50mL of buffer (2 mM MgCl2,
25 mM CaCl2, 20 mM MOPS, pH 7.4), and underwent at least five freeze/
thaw cycles to ensure proper mixing of lipids. The final lipid concentration of
3.75 mM is well within the lipid cofactor saturation regime (41). Thus, if the
multilamellarity of the lipid vesicles is changed by the addition of diacyl-
glycerol resulting in a change of the effective lipid concentration, PK-C
activity will not be affected. The lipids were then heated to 30C in a water
bath and 20 mL of substrate was added (2 mM MgCl2, 25 mM CaCl2, 20 mM
MOPS, 0.83 mg/mL Histone III-S, 20 mM ATP, 7 mCi g-32P ATP, pH 7.4
(final concentrations)). The low concentrations of CaCl2, histone, and ATP
were chosen to have minimal effects on bilayer structure (25,42). To start the
reaction, 10 ng PK-C in 10mL buffer was added to the mixture. After 5 min of
incubation, the reaction was stopped by depositing 55 mL of the mixture on
P81 filter paper circles which were then washed four times in 500 mL of
50 mM NaCl, each wash lasting 30 min. The filter paper circles were then
rinsed with acetone, and placed in scintillation vials with 2 mL scintillation
fluid and counted on a scintillation counter (Beckman Coulter, Fullerton, CA).
2H NMR measurements
The lipids (in chloroform) for the sample, including diolein, cholesterol, and
sphingomyelin as appropriate were aliquoted into cuvettes. The lipid mixture
included 5 mg d31-POPC or d31-POPS, which replaced an equivalent molar
amount of unlabeled lipid in the mixture. The chloroform was then evapo-
rated under a stream of dry N2 and 20:1 benzene/methanol (v:v) was added to
resuspend the lipids, a commonly used method which has previously been
shown to yield uniform distribution (43). The resultant mixture was then
lyophilized, hydrated in deuterium-depleted buffer (65 mM MgCl2, 40 mM
MOPS pH 7.4) at 1:2 w/w (lipid/buffer), sealed, and underwent five freeze/
thaw cycles. The MgCl2 concentration was calculated to maintain the same
ratio of PS bound to Mg21 to unbound PS in both PK-C assays and NMR
experiments, as explained in our previous publication (14).
Spectra were acquired on a Varian Inova 500 spectrometer at 11.74 T
(corresponding to a 76.77 MHz 2H frequency; Varian, Cary, NC) with a high
power 2H probe after equilibrating at the run temperature for 20 min using the
standard quadrupole echo sequence (90x–t–90y) with a refocusing time (t)
of 60 ms, a 90 pulse of 3.5 ms, a 200 ms recycle time, and a 500 kHz spectral
width. Transients were acquired until the signal/noise ratio reached an ac-
ceptable level, which typically took on the order of 10,000 transients. Ac-
quired transients were then interpolated using bicubic splines and left-shifted
to the top of the echo (44) (software available at http://rzlab.ucr.edu/nmr),
and analyzed using Felix 1.0 (http://apache.org). Numeric deconvolution (or
dePakeing) was performed using the fast Fourier transform method (45,46).
RESULTS
The dependence of PK-C activity on the presence of cho-
lesterol and diolein is depicted in Fig. 1, which shows the
results of a single typical experiment, with concentrations of
diolein between 0 and 15 mol % and concentrations of cho-
lesterol between 0 and 40 mol %. Each individual vertex of
the graph is an average of three replicates, the standard errors
of which are on the order of those given in Fig. 2. We ob-
served the classical effect of diolein-activating PK-C at all
concentrations of cholesterol tested. This effect is easily
discernible on the right-front cube face at 0 mol % choles-
terol. In the absence of diolein, cholesterol does not affect
PK-C activity, as is apparent from the left-front cube face. A
novel effect of cholesterol amplifying the increase of PK-C
FIGURE 1 Amplification by cholesterol of the activation of PK-C by
diacylglycerol. PK-C activity of samples containing various concentrations
of cholesterol (CHOL) and diolein (DO), with diolein concentration in-
creasing from the center front to the right rear, and cholesterol concentration
increasing from the center front to the left rear. Every intersection is the
mean of PK-C activity from triplicate samples from a single experiment,
with error bars corresponding to standard error omitted for clarity. See Fig. 2
for representative error sizes. The shading indicates the average activity of
each quadrilateral: lighter shading indicates higher activity.
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activity by diolein is seen in the first altitude gain on the left
side that corresponds to an increase from 0 to 10 mol %
cholesterol. The amplification by cholesterol is apparent at
low physiological concentrations of diolein (3 mol %) and
within the range of physiological cholesterol concentrations
(20–40 mol %), and persists at higher concentrations of di-
olein. There is a peak of PK-C activity at 30 mol % choles-
terol and 15% diolein, corresponding to a 1.7-fold increase
relative to the level without cholesterol; further addition of
cholesterol leads to decreased PK-C activity.
Since sphingomyelin is another major component of
cholesterol and sphingomyelin-enriched membrane domains,
we next examined the effect of sphingomyelin on PK-C ac-
tivity within the same range of concentrations of cholesterol
and diolein given above. However, as seen in Fig. 2, there
was no significant effect of sphingomyelin on PK-C activity.
The dependence of PK-C activity on the physico-chemical
parameters of the lipid cofactors has been previously dem-
onstrated by us and others (14,15,26,47–52). To understand
the mechanism behind the amplification by cholesterol of the
PK-C activation by diolein we next used 2H NMR to examine
samples with the same composition as those in PK-C assays,
except a fraction of POPC or POPS was substituted with the
corresponding acyl chain per-deuterated nonperturbing la-
bels: d31-POPC or d31-POPS, respectively. Fig. 3 shows the
2H NMR spectra of a 4:1 mol/mol mixture of POPC and
POPS at various temperatures. We have used a 4:1 ratio of
POPC to POPS as this is representative of the ratio of PC to
PS in animal membranes (53–55). The spectra are well re-
solved, and indicative of the liquid crystalline bilayer phase
with no other phases present at the temperatures shown.
These spectra are consistent with those previously observed
by us (56) and others (35,57). The spectra correspond to a
powder pattern generated by the acyl-chain deuterons at
different positions in the acyl chains and all orientations
relative to the external magnetic field. We have observed a
maximum of nine peaks, whose position corresponds to the
perpendicular orientation of the specific deuteron magnetic
moments relative to the external magnetic field. The as-
signment of these peaks to the specific positions of the acyl
chains was done according to Morrison and Bloom (57), and
reflects the relationship of the quadrupole splittings and the
order parameters of the corresponding C-D bonds (SCD,
Eq. 1, (58)),
Dni ¼

3e2qQ
4h
SCDi
; (1)
where e2qQ=h or nQ is the static quadrupole coupling
constant, 167 kHz (59), and Dni is the peak-to-peak quadru-
pole splitting of the corresponding deuteron. The order
parameters at the top of the acyl chains, close to the phos-
pholipid headgroups, have the highest values—reflected in
the largest quadrupole splittings (the plateau region) with the
top-seven position with the identical order parameters corre-
sponding to the wide-end shoulders of the spectra (Figs. 3–5)
and the plateau on the SCD plots (Fig. 6). The order param-
eters monotonously decrease along the chains with the
terminal methyl corresponding to the least-ordered, well-
resolved inner pair of symmetrical peaks (Figs. 3–5.) The SCD
profiles of d31-POPC and d31-POPS are slightly different
(Fig. 6) for mixtures which do not contain diolein. The
individual peaks of d31-POPC spectra (Fig. 4, A, D, and G;
and Fig. 5, A and D) are broader than those of d31-POPS
spectra (Fig. 4, J, M, and P; and Fig. 5, J and M). This
observation is consistent with previously reported differences
between cholesterol interactions with PC or PS (60,61),
although the exact mechanism for this difference is not clear
(61). We also cannot completely exclude the possibility of
lateral phase separation of domains slightly enriched in
cholesterol in the absence of diolein. This peak broadening
is abolished by addition of diacylglycerol, making the d31-
POPC and d31-POPS spectra virtually superimposable (see
corresponding panels on Figs. 4 and 5), and thus is unlikely to
have an effect on PK-C activity which requires the presence
of diacylglycerol. The SCD profiles of d31-POPC and d31-
POPS differ slightly in their behavior upon the addition of
diolein to mixtures containing cholesterol: diolein slightly
increases the ordering of d31-POPC containing membranes,
while it has the opposite effect on d31-POPS, though the
effects are small.
Whereas in the absence of cholesterol addition of diolein
increased the order parameters of both PC and PS, consistent
with our previous results (14,15), in the presence of choles-
terol this effect became insignificant (Fig. 6). These results
are similar to our previous results obtained with addition of
d62-DPPC or d62-DPPS to bilayers composed of bovine liver
PC extracts, DPPC, and DPPS (25).
FIGURE 2 Dependence of PK-C activity on sphingomyelin. PK-C activ-
ity of samples containing sphingomyelin (SM ) amounts ranging from 0 mol
% to 20 mol % without PK-C (s), with PK-C (n), with 3 mol % diolein (=),
with 10 mol % diolein (3), and with 10 mol % diolein and 25 mol %
cholesterol ()).
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The average area-per-lipid-molecule of d31-POPC and d31-
POPS calculated using the SCD values and the mean torque
model (and methyl volume formula given therein) (62) results
in areas at 30C of 60.6 A˚2 for mixtures without cholesterol or
diolein, decreasing to 50.3 A˚2 at 40 mol % cholesterol and
15 mol % diolein. These areas are smaller than those reported
by Greenwood et al. (63), but are similar to the areas calcu-
lated by simulation (64) and experiment (65).
Fig. 4 shows the 2H NMR spectra of POPC and POPS (4:1
mol/mol) labeled with d31-POPC (Fig. 4, A–I) or d31-POPS
(J-R) mixed with 25 mol % cholesterol, 10 mol % diolein, or
both at 30, 60, and 75C (as indicated). With 25% choles-
terol, the spectra are substantially less well resolved and
significantly wider (more ordered) than the corresponding
spectra without cholesterol, indicative of the presence of the
liquid-ordered phase (lo) (56,66,67) at the temperatures
shown (Fig. 4, A, D, and G). DePakeing (45,46) of this and
other cholesterol-containing spectra did not result in a sig-
nificant improvement of the resolution and specifically did
not allow us to discern any additional peaks (not shown).
With 10% diolein, the spectra are slightly wider than the
corresponding spectra without diolein, better resolved, and
are in a bilayer phase at all temperatures shown (Fig. 4, B,
E, and H). This bilayer-ordering effect of diolein and other
diacylglycerols has been shown by us previously (15,47).
When 10% diolein and 25% cholesterol are added together,
however, an isotropic, nonbilayer phase (central peak) is
observed at 75C (Fig. 4, I and R). This nonbilayer phase is
not observed at lower temperatures (Fig. 4, C and F). These
spectra are also significantly better resolved than the corre-
sponding spectra without diolein, perhaps corresponding to a
decrease in the range of available local cholesterol concen-
trations. An alternative possibility is the partial orientation of
diolein-containing spectra, most likely due to the high-field
FIGURE 3 2H NMR spectra of mixtures of
POPC/POPS 4:1 w/w with d31-POPC (A, C, and
E) or d31-POPS (B, D, and F) at 30 (A and B), 60
(C and D), and 75C (E and F).
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FIGURE 4 2H NMR spectra of mixtures of POPC/POPS 4:1 w/w with d31-POPC (A–I ) or d31-POPS (J–R) and 25% cholesterol and/or 10% diolein at 30,
60, and 75C.
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FIGURE 5 2H NMR spectra of mixtures of POPC/POPS 4:1 w/w with d31-POPC (A–I ) or d31-POPS (J–R) and 40% cholesterol and/or 15% diolein at 30,
60, and 75C.
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strength of the instrument used. However, this does not alter
the splittings at the 90 position, and consequently does not
alter the SCD (68). The samples containing d31-POPS behave
similarly, with slightly higher order parameters consistent
with previously published results (56). Although Fig. 4 R
(25% cholesterol, 10% diolein, d31-POPS) shows a higher
intensity central peak than the corresponding d31-POPC la-
beled spectra (Fig. 4 I ) the relative areas (corresponding to
the distribution of the labeled lipids between the phases) are
similar, indicating that there is no significant difference in
d31-POPC and d31-POPS distribution among the lipid phases.
The amplification by cholesterol of the inducement of
nonbilayer lipid phases by diolein is even more pronounced
upon increase of cholesterol concentration to 40 mol %,
which is within the range of physiological cholesterol con-
centrations in the plasma membrane (53–55) (Fig. 5). In-
creasing cholesterol to 40 mol % also results in further
widening of the spectra, as compared to 25 mol % cholesterol
(Fig. 4), consistent with the ordering effect of cholesterol.
With 15% diolein (DO) (Fig. 5, B, E, and H), the spectra
are still well resolved (in the absence of cholesterol) and
slightly more ordered than the corresponding spectra with
10% diolein (Fig. 4 B, E, and H). Spectra with both 40%
cholesterol and 15% diolein show the presence of an isotropic
phase (small vesicles or micelles), coexisting with a liquid-
ordered phase, which becomes more pronounced at higher
temperatures (Fig. 5, F, I, O, and R).
DISCUSSION
In our previous studies we have demonstrated that diacyl-
glycerols, alone or in combination with other lipid second-
messenger molecules, such as unesterified fatty acids or
ceramides, activate PK-C and perturb (generally by destabi-
lizing) lipid bilayer structure (14,15,25,26). Furthermore, we
reached the conclusion that the combined bilayer perturbation
induced by diacylglycerols and other second messengers is
the driving force in their combined effects on PK-C activity.
In this study, we have continued our previous work by
studying such important cell membrane components as cho-
lesterol and sphingomyelin. To examine the effect of lipid
bilayer structure on PK-C activity, we have used 2H NMR,
which is able to determine the chain order and phase com-
position of membranes nearly identical to those used for PK-C
assays while minimizing perturbation due to the label, as often
occurs when using fluorescent or electron spin resonance
probes (69). This allows us to infer relationships between the
physicochemical parameters of the membrane, such as the
propensity to form nonbilayer phases, and the level of PK-C
activation measured by the PK- C assay.
Cholesterol modulates activities of
membrane-associated enzymes
We have found profound combined effects of diacylglycerol
and cholesterol on both PK-C activity and lipid bilayer
structure. The presence of cholesterol in combination with
diacylglycerol amplifies both the diacylglycerol-induced PK-
C activity (Fig. 1) and the propensity of the lipids to adopt
nonbilayer phases, which is pronounced even at 25% cho-
lesterol with 10% diolein (Fig. 4, C, F, and I ), and closely
corresponds to the maximum PK-C activity (Fig. 1). This
supports the previously presented hypothesis (24,26,49) that
this propensity is a factor promoting PK-C activity. We (and
others) have consistently detected increases in PK-C activity
induced by a variety of lipophilic compounds (14,15,25,
50–52), which by themselves do not activate PK-C, but de-
stabilize bilayers by increasing their propensity to adopt
nonbilayer lipid phases. Conversely, compounds that de-
crease this propensity (i.e., seem to stabilize bilayers) atten-
uate PK-C activity (50–52).
FIGURE 6 SCD plot of d31-POPC (A) and d31-POPS (B) labeled spectra at
30C. Missing points correspond to locations where peaks could not be
unambiguously assigned. (Labels: s, 4:1 POPC/POPS alone; n, with 40%
cholesterol;1, with 15% diolein;3, with 40% cholesterol and 15% diolein;
) with 25% cholesterol; , with 10% diolein; k , with 25% cholesterol and
10% diolein.)
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The simplest explanation of these observations is that the
bilayer instability observed as the increased propensity to
adapt nonbilayer lipid phases is an important factor in PK-C
activation. Also, consistent with our previous findings (14,15),
the actual presence of nonbilayer phases at the temperature of
PK-C assays, exhibited by 40% cholesterol and 15% diolein
(Fig. 5, C, F, and I), is detrimental to PK-C activity, as can be
seen on Fig. 1. It has previously been shown that the addition
of cholesterol to model membranes can promote phase sepa-
ration in phosphatidylethanolamine (PE)/PS (70), the cubic
nonbilayer phase in dioleoyl-phosphatidylcholine-containing
mixtures (71) (although these phases were only seen transiently
with POPC/cholesterol mixtures), and the formation of iso-
tropic vesicles in bovine brain-PC/d31-POPC/cholesterol/
diolein mixtures at 60C (56).
Our results at 40 mol % cholesterol, which show a sig-
nificant increase in order parameters induced by cholesterol,
are consistent with the bilayers being in the liquid-ordered
(lo) phase. Different conclusions were reached recently in a
similar system: Filippor et al. (72) concluded from the low
activation energy and linear decrease of lipid diffusion co-
efficient with the addition of cholesterol that the bilayers are
in liquid-disordered (ld) phase at this temperature. However,
work by Aussenac et al. (73) using 2H NMR of cholester-
ol-2H5 indicates that mixtures of POPC containing .22%
cholesterol are in lo; these conclusions are also in agreement
with published phase diagrams of Veatch and Keller (74), de
Almeida et al. (75), and our previous work (56).
Our results are consistent with a few reports that showed
increased activity of PK-C in the presence of cholesterol (76–
78). Cholesterol sulfate has also previously been implicated
in the activation of certain PK-C isozymes (79). Furthermore,
cholesterol has also been shown to be an important modulator
of other membrane-associated proteins. A study by Escriba´
and co-workers with G-proteins has shown that the addition
of cholesterol favors the binding of G-proteins to membranes
at lower concentrations (10–20 mol %) but then decreases at
higher concentrations (30–50 mol %) (19), qualitatively
similar to the biphasic response seen in the PK-C assays
presented here, where increasing cholesterol beyond a certain
point at high diolein decreases the activity of PK-C. Cho-
lesterol has also been shown to reduce the lag phase of the
activation of PL-C, presumably by increasing the frustration
in the membrane, and thereby allowing less hindered access
of PL-C to lipids in the membrane (21).
Diacylglycerols affect activities of
membrane-associated enzymes
Diacylglycerols, such as diolein, are important membrane
components and are required cofactors for the activation of
classical and novel PK-C isozymes (80). Diacylglycerols
increase the affinity of PK-C for PS-containing membranes
by two orders of magnitude (17), both by the binding of
PK-C’s C1 domain to diacylglycerol and by increasing the
intrinsic negative curvature of the bilayer (81), in so doing
increasing the propensity of the bilayer to form nonbilayer
phases. In addition to their effect on PK-C, diacylglycerols
also modulate the activities of other enzymes which have the
diacylglycerol-binding C1 domain, including the Ras gua-
nyl-releasing protein family of nucleotide exchange factors,
protein kinase D, and serine threonine kinases (82) as well as
some membrane-associated enzymes which do not have C1
domains, such as colipase (20).
Sphingomyelin does not affect PK-C activity or
bilayer structure
Sphingomyelin, a component of lipid rafts which is found
predominantly in the outer leaflet (83,84), does not have a
significant modulating effect on PK-C activity, the order
parameters of PC or PS in the lipid bilayer, or the presence of
nonbilayer lipid phases under the conditions of this study.
This was rather unexpected, as it has been previously re-
ported that sphingomyelin stabilizes PE/PS mixtures against
the HII transition (70).
Physiological relevance of
membrane composition
The concentrations of cholesterol, diacylglycerols, sphingo-
myelin, and phospholipids vary among cell types (53,55,85),
and more importantly, vary within the plasma membranes
themselves. Membrane domains (of which ‘‘lipid rafts’’ are a
subset) are regions of distinct lipid and protein composition
(54,86,87) with correspondingly distinct physicochemical
parameters. We have examined a range of cholesterol,
sphingomyelin, and diacylglycerol concentrations to under-
stand the physical behavior of model membranes corre-
sponding to modulated PK-C activity. We used a maximum of
20 mol % sphingomyelin, which is lower than the concen-
tration of sphingomyelin found in the canonical lipid-raft
mixture (33 mol %) (88). However, it encompasses the range
of the concentrations found within the inner leaf of the plasma
membrane (53,89). In the case of diacylglycerols, concen-
trations on the order of a few mol % can activate PK-C.
However, the diacylglycerols which activate PK-C are pro-
duced in close proximity to the signaling stimulus by PL-C
with localized, transiently high concentration. This concen-
tration is likely to be larger than the overall concentration of
diacylglycerol (which can reach 10 mol % in some trans-
formed cells (27)), making the range of diolein concentrations
utilized here appropriate. As for cholesterol, it has been noted
that many domains of the plasma membrane have concen-
trations of cholesterol which differ from the bulk membrane
(53,90). Traditionally, most of the membrane surface was
considered to be in a continuous ld phase, with smaller, un-
connected domains of higher cholesterol levels in lo phase
(giving rise to the term ‘‘rafts’’). However, given that the
overall concentration of cholesterol present in most cells is on
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the order of 30–50 mol % and that the lo phase is often present
at concentrations at 20–25 mol % cholesterol, it is more likely
that the lo forms the continuous phase, with the smaller do-
mains with reduced cholesterol being in ld phase (91) (we
suggest calling these ld domains ‘‘ponds’’).
CONCLUSIONS
The ability of cholesterol to amplify the activation of PK-C
and the destabilization of the bilayer phase by diacylglycerol
makes it clear that membrane regions with varying concen-
trations of cholesterol can have a significant modulating effect
upon the function of membrane-associated signal transduc-
tion proteins that are sensitive to bilayer strain. In the case of
PK-C and its activator diacylglycerol, regions of greater
cholesterol content will be more sensitive to the production of
diacylglycerol than regions with lesser cholesterol content.
It has been reported that cholesterol concentrations in the
raft and nonraft regions are 34 mol % and 15 mol %, respec-
tively (53). This change in cholesterol content corresponds to
1.5 increase in PK-C activity (Fig. 1). Thus, raft-associated
receptors will be 50% more efficient in activating PK-C than
nonassociated receptors, suggesting that different classes of
membrane domains will have distinct signal transduction
characteristics due to their variable cholesterol content, in
addition to other properties, such as the selective association
of membrane proteins with specific membrane domains.
These results, in conjunction with previous studies, can
modify the conceptual understanding of cell membranes from
performing primarily structural functions to active partici-
pants in transmembrane signal transduction.
We thank Dr. D. B. Borchardt for his help in optimizing 2H NMR experi-
ments.
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